SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:oru-94887"
 

Search: onr:"swepub:oai:DiVA.org:oru-94887" > Premature epiphysea...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Premature epiphyseal fusion induced by a retinoic acid agonist in a young girl with fibrodysplasia ossificans progressiva

Hallgrimsdottir, Sigrun (author)
Karolinska Institutet, Stockholm, Sweden; University Hospital, Stockholm, Sweden
Nilsson, Ola, 1970- (author)
Örebro universitet,Institutionen för medicinska vetenskaper,Karolinska Institutet, Stockholm, Sweden; University Hospital, Stockholm, Sweden
 (creator_code:org_t)
S. Karger, 2021
2021
English.
In: Hormone Research in Paediatrics. - : S. Karger. - 1663-2818 .- 1663-2826. ; 94:Suppl. 1, s. 95-95
  • Journal article (other academic/artistic)
Abstract Subject headings
Close  
  • Retinoic acid receptor agonists can have dramatic negative effects on growth and even induce premature growth cessation and epiphyseal fusion (1, 2).An 11 5/12-year-old, prepubertal girl with fibrodysplasia ossificans progressiva presented in our pediatric skeletal disorders clinic with the concern of early growth cessation. She had participated in a clinical trial of Palovarotene (“MOVE”, NCT03312634), a retinoic acid receptor-gamma agonist, since the age of 9 10/12 years. At the visit, she had recently discontinued her participation in the study. During the 19 months since starting on Palovarotene, her height had only increased 1.9 cm to 136.4 cm. A skeletal survey detected fusion of several growth plates that normally remain open until the end of puberty including the growth plates of proximal humerus, distal ulna and distal radius. One year after stopping Palovarotene, she was in early puberty and her height had increased another 3.9 cm to 140.3 cm (-2.6 SDS). Measurements of height, sitting height, and arm span confirmed that growth of arms and legs had ceased, whereas growth of the spine continued.This report supports previous findings indicating that highdose retinoic acid receptor agonists can induce premature epiphyseal fusion even before puberty and may therefore cause significant, disproportionate short stature if used in young children. The finding that growth of the spine, but not legs and arms, resumed after the treatment was discontinued suggests that long bones are more susceptible than vertebrae to retinoic acid-induced epiphyseal fusion.1. De Luca F, Uyeda JA, Mericq V, Mancilla EE, Yanovski JA, Barnes KM, et al. Retinoic acid is a potent regulator of growth plate chondrogenesis. Endocrinology. 2000;141(1):346–53.2. Pease CN. Focal retardation and arrestment of growth of bones due to vitamin A intoxication. JAMA. 1962;182:980–5.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Pediatrik (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Pediatrics (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)

Publication and Content Type

vet (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Hallgrimsdottir, ...
Nilsson, Ola, 19 ...
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Pediatrics
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Endocrinology an ...
Articles in the publication
Hormone Research ...
By the university
Örebro University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view